Senior Specialist - Regulatory & Compliance

Set up as a new job alert
  1. Permanent
  2. English
  3. Not Applicable*
  4. Legal, Regulatory & Compliance
  5. Zurich
  6. Commodities & Natural Resource
  7. Regulatory & Compliance, Commodities, EMIR, REMIT, MiFID, Trading, Derivatives
This vacancy has now expired
On behalf of our client, an established and international multi-commodity energy company, Swisslinx is seeking a Senior Specialist - Regulatory & Compliance, to join their office in the Zurich area.

The main purpose of this position would be to develop and implement a regulatory framework and internal standards and policies – in abidance with relevant domestic and international standards.

Your Mission:

- Governance of MIFID, EMIR, REMIT and other relevant regulations in relations to the group`s trading activities
- Support front office, keep track of regulatory performance and mitigate any adherence or policy gaps
- Establish and implement a regulatory framework – policies and guidelines – in addition to being the first point of contact with external regulatory bodies
- Produce quality regulatory reporting, both internally and externally
- Maintenance of established framework and ensuring adherence by creating worships and training to disperse information

Your Background:

- University level degree from a recognised institution
- At least 5 years of professional experience working in a derivatives trading or exchange environment, supporting and implementing regulatory / compliance topics
- Coming from the commodities sector, or investment banking (commodities desk)
- Knowledge is EMIR, REMIT, MiFID as well as other regulations are a plus
- Fluent in English, other languages a plus

Our client offers a dynamic and international working environment – with the opportunity to have hands on experience designing and shaping the group`s regulatory strategy.

If you think your profile is a good fit, please send me your CV to

Look forward to hearing from you!

How has Covid-19 impacted Dubai?


How have startups pivoted to respond to Covid-19?